Alkermes plc

21.29+0.3700+1.77%Vol 182.91K1Y Perf 34.57%
Apr 23rd, 2021 10:46 DELAYED
BID21.29 ASK21.30
Open21.10 Previous Close20.92
Pre-Market- After-Market-
 - -%  - -
Target Price
22.22 
Analyst Rating
Hold 2.80
Potential %
4.52 
Finscreener Ranking
★★+     49.16
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     49.53
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     53.89
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap3.39B 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
75.85 
Earnings Date
28th Apr 2021

Today's Price Range

20.7621.31

52W Range

13.0323.92

5 Year PE Ratio Range

-33.90-17.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
5.28%
1 Month
7.95%
3 Months
-5.72%
6 Months
27.64%
1 Year
34.57%
3 Years
-53.70%
5 Years
-50.97%
10 Years
50.50%

TickerPriceChg.Chg.%
ALKS21.290.37001.77
AAPL133.481.54001.17
GOOG2 292.6224.70001.09
MSFT258.991.82000.71
XOM55.680.41000.74
WFC43.550.85001.99
JNJ165.640.46000.28
FB298.552.03000.68
GE13.560.15001.12
JPM149.602.23001.51
Financial StrengthValueIndustryS&P 500US Markets
2.10
2.50
0.27
0.38
-10.10
Leverage Ratio 1.80
ProfitabilityValueIndustryS&P 500US Markets
44.90
-8.50
-0.60
-17.60
-8.88
RevenueValueIndustryS&P 500US Markets
792.54M
4.98
3.85
12.41
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.04-0.05-25.00
Q03 2020-0.140.12185.71
Q02 2020-0.13-0.0838.46
Q01 2020-0.27-0.0966.67
Q04 20190.490.6940.82
Q03 2019-0.38-0.2242.11
Q02 2019-0.26-0.0676.92
Q01 2019-0.39-0.3315.38
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.21-162.50Negative
6/2021 QR-0.06-700.00Negative
12/2021 FY-0.19-371.43Negative
12/2022 FY0.71-5.33Negative
Next Report Date28th Apr 2021
Estimated EPS Next Report-0.21
Estimates Count4
EPS Growth Next 5 Years %35.60
Volume Overview
Volume182.91K
Shares Outstanding159.24M
Trades Count1.65K
Dollar Volume19.64M
Avg. Volume1.27M
Avg. Weekly Volume1.13M
Avg. Monthly Volume1.02M
Avg. Quarterly Volume1.22M

Alkermes plc (NASDAQ: ALKS) stock closed at 20.92 per share at the end of the most recent trading day (a 2.05% change compared to the prior day closing price) with a volume of 1.57M shares and market capitalization of 3.39B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 2245 people. Alkermes plc CEO is Richard F. Pops.

The one-year performance of Alkermes plc stock is 34.57%, while year-to-date (YTD) performance is 4.86%. ALKS stock has a five-year performance of -50.97%. Its 52-week range is between 13.03 and 23.92, which gives ALKS stock a 52-week price range ratio of 75.85%

Alkermes plc currently has a PE ratio of -28.40, a price-to-book (PB) ratio of 2.97, a price-to-sale (PS) ratio of 4.03, a price to cashflow ratio of 38.10, a PEG ratio of 2.32, a ROA of -5.66%, a ROC of -5.15% and a ROE of -9.86%. The company’s profit margin is -8.88%, its EBITDA margin is -0.60%, and its revenue ttm is $792.54 Million , which makes it $4.98 revenue per share.

Of the last four earnings reports from Alkermes plc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.21 for the next earnings report. Alkermes plc’s next earnings report date is 28th Apr 2021.

The consensus rating of Wall Street analysts for Alkermes plc is Hold (2.8), with a target price of $22.22, which is +4.52% compared to the current price. The earnings rating for Alkermes plc stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Alkermes plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Alkermes plc has a Buy technical analysis rating based on Technical Indicators (ADX : 8.89, ATR14 : 0.81, CCI20 : 192.95, Chaikin Money Flow : 0.09, MACD : -0.02, Money Flow Index : 80.59, ROC : 9.47, RSI : 64.08, STOCH (14,3) : 93.26, STOCH RSI : 1.00, UO : 60.84, Williams %R : -6.74), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Alkermes plc in the last 12-months were: Blair C. Jackson (Option Excercise at a value of $0), Christian Todd Nichols (Option Excercise at a value of $0), Craig C. Hopkinson (Option Excercise at a value of $0), Craig C. Hopkinson (Sold 28 920 shares of value $570 288 ), David Joseph Gaffin (Option Excercise at a value of $0), David W. Anstice (Option Excercise at a value of $298 400), David W. Anstice (Sold 17 832 shares of value $299 310 ), Iain M. Brown (Option Excercise at a value of $780 425), Iain M. Brown (Sold 47 500 shares of value $892 304 ), James M. Frates (Option Excercise at a value of $258 080), Michael J. Landine (Option Excercise at a value of $604 814), Michael J. Landine (Sold 43 000 shares of value $634 894 ), Paul J. Mitchell (Option Excercise at a value of $298 400), Paul J. Mitchell (Sold 20 000 shares of value $332 262 ), Richard F. Pops (Option Excercise at a value of $1 467 500), Richard F. Pops (Sold 125 000 shares of value $1 856 497 ), Wendy L. Dixon (Option Excercise at a value of $806 700), Wendy L. Dixon (Sold 25 000 shares of value $500 120 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (10.00 %)
1 (9.09 %)
1 (8.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
9 (90.00 %)
10 (90.91 %)
11 (91.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.80
Hold
2.82
Hold
2.83

Alkermes plc

Alkermes PLC is a fully integrated global biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in major therapeutic areas. The company utilizes several collaborative arrangements to develop and commercialize products and, in so doing, to access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies.

CEO: Richard F. Pops

Telephone: +353 17728000

Address: 1 Burlington Road, Dublin D04 C5Y6, , IE

Number of employees: 2 245

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

63%38%

Bearish Bullish

61%39%

Bearish Bullish

63%37%

News

Stocktwits